Combination RASG12C(ON) and RASMULTI(ON) inhibition overcomes resistance and prolongs durability in preclinical models of mutant KRASG12C-driven cancers

被引：0
|
作者：
Wei, Xing
Holderfield, Matthew
Yang, Yu Chi
Seamon, Kyle
Dinglasan, Jay
Montazar, Nilufar
Lee, Bianca
Cai, Shurui
Lai, Lick
Aronchik, Ida
Chang, Stephanie
Wang, Zhican
Wildes, Pete
Smith, Jacqueline A.
Jiang, Jingjing
Singh, Mallika
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-6585
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6585
引用
收藏
页数：2
相关论文
共 38 条
  • [1] Cooperative anti-tumor effects of combined inhibition of KRASG12C plus autophagy in preclinical models of KRASG12C-driven lung cancer
    Ghazi, Phaedra C.
    Kinsey, Conan
    Bogdan, Madhumita
    Smith, Bryan D.
    Flynn, Daniel L.
    McMahon, Martin
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [2] Pan-ErbB inhibition enhances activity of KRASG12C inhibitors in preclinical models of KRASG12C mutant cancers
    Robichaux, Jacqulyne P.
    Galan-Cobo, Ana
    Powell, Ried T.
    Gale, Kelly A.
    He, Jun
    Zhang, Fahao
    Nilsson, Monique B.
    Zhang, Xiang
    Sobieski, Mary M.
    Nguyen, Nghi
    Clifford, Stephan C.
    Heymach, John V.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [3] TEAD inhibition overcomes YAP1/TAZ-driven resistance to RAS inhibitors in KRASG12C-mutant cancers
    Edwards, Alexander C.
    Stalnecker, Clint A.
    Morales, Alexis J.
    Taylor, Khalilah E.
    Hallin, Jill
    Olson, Peter
    Tang, Tracy T.
    Engstrom, Lars
    Post, Leonard
    Christensen, James G.
    Cox, Adrienne D.
    Der, Channing J.
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [4] Vertical inhibition overcomes adaptive resistance to KRASG12C inhibition
    Ryan, Meagan B.
    de la Cruz, Ferran Fece
    Phat, Sarah
    Myers, David T.
    Shahzade, Heather A.
    Hong, Catriona B.
    Corcoran, Ryan B.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [5] Adaptive Mechanisms and Synergistic Combinations to Overcome Sotorasib Resistance in KRASG12C-Driven NSCLC
    Arantes Megid, R.
    Gomes Ribeiro, G.
    Natalia Faria Gomes, I.
    Carolina Laus, A.
    Ferro Leal, L.
    Sussuchi Da Silva, L.
    Bakr Ariwoola, A.
    Mourao Dias, J.
    Manuel Reis, R.
    Jose Da Silva Oliveira, R.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S143 - S144
  • [6] Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRASG12C Inhibition
    Ryan, Meagan B.
    de la Cruz, Ferran Fece
    Phat, Sarah
    Myers, David T.
    Wong, Edmond
    Shahzade, Heather A.
    Hong, Catriona B.
    Corcoran, Ryan B.
    CLINICAL CANCER RESEARCH, 2020, 26 (07) : 1633 - 1643
  • [7] Assessing Therapeutic Efficacy of MEK Inhibition in a KRASG12C-Driven Mouse Model of Lung Cancer
    Li, Shuai
    Liu, Shengwu
    Deng, Jiehui
    Akbay, Esra A.
    Hai, Josephine
    Ambrogio, Chiara
    Zhang, Long
    Zhou, Fangyu
    Jenkins, Russell W.
    Adeegbe, Dennis O.
    Gao, Peng
    Wang, Xiaoen
    Paweletz, Cloud P.
    Herter-Sprie, Grit S.
    Chen, Ting
    Gutierrez-Quiceno, Laura
    Zhang, Yanxi
    Merlino, Ashley A.
    Quinn, M.
    Zeng, Yu
    Yu, Xiaoting
    Liu, Yuting
    Fan, Lichao
    Aguirre, Andrew J.
    Barbie, David A.
    Yi, Xianghua
    Wong, Kwok-Kin
    CLINICAL CANCER RESEARCH, 2018, 24 (19) : 4854 - 4864
  • [8] Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers
    Khan, Husain Yar
    Nagasaka, Misako
    Aboukameel, Amro
    Alkhalili, Osama
    Uddin, Md. Hafiz
    Bannoura, Sahar F.
    Mzannar, Yousef
    Azar, Ibrahim
    Beal, Eliza W.
    Tobon, Miguel E.
    Kim, Steve H.
    Beydoun, Rafic
    Baloglu, Erkan
    Senapedis, William
    El-Rayes, Bassel F.
    Philip, Philip A.
    Mohammad, Ramzi M.
    Shields, Anthony F.
    Al Hallak, Mohammed Najeeb
    Azmi, Asfar S.
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12) : 1422 - 1433
  • [9] RMC-6291, a next-generation tri-complex KRASG12C(ON) inhibitor, outperforms KRASG12C(OFF) inhibitors in preclinical models of KRASG12C cancers
    Nichols, Robert J.
    Yang, Y. C.
    Cregg, Jim
    Schulze, Chris J.
    Wang, Zhican
    Dua, Richa
    Jiang, Jingjing
    Garrenton, Lindsay S.
    Nasholm, Nicole
    Bermingham, Alun
    Knox, John E.
    Seamon, Kyle
    Longhi, Michael
    Chou, Kang-Jye
    Li, Shaoling
    Wildes, David P.
    Singh, Mallika
    Koltun, Elena S.
    Gill, Adrian L.
    Smith, Jacqueline A. M.
    CANCER RESEARCH, 2022, 82 (12)
  • [10] TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors
    Edwards, A. Cole
    Stalnecker, Clint A.
    Morales, Alexis Jean
    Taylor, Khalilah E.
    Klomp, Jennifer E.
    Klomp, Jeffrey A.
    Waters, Andrew M.
    Sudhakar, Niranjan
    Hallin, Jill
    Tang, Tracy T.
    Olson, Peter
    Post, Leonard
    Christensen, James G.
    Cox, Adrienne D.
    Der, Channing J.
    CANCER RESEARCH, 2023, 83 (24) : 4112 - 4129
1234